Abstract
Iterative protein structure-based ligand design has led to a 'selective' inhibitor of human nonpancreatic secretory phospholipase A(2) which provides a new tool for probing metabolic pathways and may lead to a useful drug.
Original language | English |
---|---|
Pages (from-to) | 429-432 |
Number of pages | 4 |
Journal | Nature Structural Biology |
Volume | 2 |
Issue number | 6 |
Publication status | Published - Jun-1995 |
Keywords
- SYNOVIAL-FLUID PHOSPHOLIPASE-A2
- INDOMETHACIN
- RESOLUTION